₹ 5,398.50
94.50 (1.78%)
A
Alkem Laboratories
₹ 5,398.50
Alkem Laboratories EPS Summary (consolidated)
The latest quarterly EPS of Alkem Laboratories as of Q1 Jun 2026 stands at ₹43.49. This is a 119.98% growth quarter on quarter and 21.72% fall same quarter last year. The forecasted EPS for Q1 Jun 2026 was ₹34.20. It beat the estimate by ₹9.29. For the FY2026 the EPS of Alkem Laboratories stands at ₹192.51. This is a 6.29% growth compared with FY2025.
Alkem Laboratories EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

